Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

A-S Medication Solutions Metformin Hydrochloride Recalled for Foreign Tablets

Agency Publication Date: March 21, 2025
Share:
Sign in to monitor this recall

Summary

A-S Medication Solutions LLC has recalled 411 180-count bottles of Metformin Hydrochloride Extended-Release 500mg, a medication used to manage blood sugar in adults with type 2 diabetes. This recall was issued because foreign tablets or capsules were found inside the medication bottles, meaning patients could unknowingly ingest the wrong drug. The affected medication was distributed nationwide in the United States and is identified by NDC 50090-1494-3.

Risk

Taking an unknown medication by mistake can lead to serious side effects, harmful drug interactions, or allergic reactions. It also means the patient is not receiving their prescribed dose of metformin, which could lead to uncontrolled blood sugar levels.

What You Should Do

  1. The recalled medication is Metformin Hydrochloride Extended-Release 500mg sold in 180-count bottles (NDC 50090-1494-3) with lot number 4260340 and an expiration date of 12/31/2025.
  2. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  3. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Metformin Hydrochloride Extended-Release 500mg (180 tablets)
Variants: 500mg, Extended-Release, Tablet
Lot Numbers:
4260340 (Exp 12/31/2025)
NDC:
50090-1494-3

Packaged by: A-S Medication Solutions, Libertyville, IL 60048.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96313
Status: Active
Manufacturer: A-S Medication Solutions LLC
Sold By: Pharmacies nationwide
Manufactured In: United States
Units Affected: 411 180-count bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.